Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Serum Splicing Factor Proline- and Glutamine-Rich Is a Diagnostic Marker for Non-Small-Cell Lung Cancer and Other Solid Cancers

International Journal of Molecular Sciences(2024)10.3390/ijms25168766Source: DataRank Database

Serum Splicing Factor Proline- and Glutamine-Rich Is a Diagnostic Marker for Non-Small-Cell Lung Cancer and Other Solid Cancers is a research paper published in International Journal of Molecular Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

hpa

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.16)OA: goldTopics (61)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Adam Gilbertsen ORCID,Blake A. Jacobson,Robert A. Kratzke ORCID,Craig A. Henke ORCID,Libang Yang ORCID

Live enrichment

PubMed:39201453 PMC:PMC11354699 OpenAlex:https://openalex.org/W4401590466

National Institute of Health

Grant: R01 HL125227

National Institute of Health

Grant: UL1TR002494

NIH HHS

Grant: R01 HL125227, UL1TR002494

National Institutes of Health

Grant: 5R01HL125227-03

Integrin-Matrix Regulation of IPF Fibroblast Phenotype

National Institutes of Health

Grant: 3UL1TR002494-02S1

University of Minnesota Clinical and TranslationalmScience Institute (UMN CTSI)

FWCI

0.16

Citation Percentile

0.5%

Citation Trend

2025

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/25/16/8766/pdf?version=1723456177

publisherhttps://www.mdpi.com/1422-0067/25/16/8766/pdf?version=1723456177

publisherhttps://www.mdpi.com/1422-0067/25/16/8766/pdf

journalhttps://doi.org/10.3390/ijms25168766

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39201453

Fields of Study

RNA Research and SplicingRNA modifications and cancerRNA and protein synthesis mechanisms0301 basic medicine0303 health sciences03 medical and health sciencesHumansCarcinoma, Non-Small-Cell LungBiomarkers, TumorLung NeoplasmsPTB-Associated Splicing FactorFemaleMaleEnzyme-Linked Immunosorbent AssayMiddle AgedNeoplasmsAged

MeSH Terms

PTB-Associated Splicing FactorAgedCarcinoma, Non-Small-Cell LungEnzyme-Linked Immunosorbent AssayFemaleHumansLung NeoplasmsMaleMiddle AgedNeoplasmsBiomarkers, Tumor

Keywords

Splicing factorLung cancerCancer researchMetastasisBiomarkerCancer cellCancerImmunohistochemistryMedicineBiologyRNA splicingImmunologyOncologyInternal medicineGeneRNABiochemistryNSCLCDiagnostic MarkerSolid CancersSfpqMaleLung NeoplasmsEnzyme-Linked Immunosorbent AssayMiddle AgedArticleCarcinoma, Non-Small-Cell LungNeoplasmsBiomarkers, TumorHumansFemalePTB-Associated Splicing FactorAged

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Serum Splicing Factor Proline- and Glutamine-Rich Is a Diagnostic Marker for Non-Small-Cell Lung Cancer and Other Solid Cancers

FAIR Checklist

Authors (5)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)